Skip to main content
. 2012 Nov;53(11):2436–2442. doi: 10.1194/jlr.P026328

TABLE 1.

Cause of death by treatment group and atorvastatin dose

Atorvastatin dose
10 mg
20 mg
40 mg
80 mg
Number of subjects T/A 3,218 A 3,274 T/A 2,036 A 2,027 T/A 1,508 A 1,559 T/A 771 A 674
Event Number of events
All Deaths 50 19 21 17 12 12 10 11
Any CV cause 30 13 11 9 4 6 4 7
Sudden death 15 8 5 7 3 4 3 6
Fatal MI (not procedure related) 6 2 2 2 0 1 0 1
Fatal stroke 3 0 2 0 1 0 0 0
Hemorrhagic 1 0 2 0 1 0 0 0
Ischemic 2 0 0 0 0 0 0 0
Embolic 0 0 0 0 0 0 0 0
Fatal heart failure 2 0 0 0 0 1 0 0
Other vascular cause 1 2 0 0 0 0 0 0
Fatal MI (procedure related) 2 0 0 0 0 0 0 0
Other cardiac cause 1 1 2 0 0 0 1 0
Any non-CV cause 19 6 9 6 6 4 6 4
Cancer 12 5 4 3 4 4 4 2
Infection 3 0 3 0 2 0 1 0
Trauma 1 1 1 2 0 0 1 0
Suicide or homicide 0 0 0 1 0 0 0 0
Other cause 3 0 1 0 0 0 0 2
Reason unknown 1 0 1 2 2 2 0 0

T/A: torcetrapib plus atorvastatin; A atorvastatin alone; CV: cardiovascular; MI: myocardial infarction.